Technology Results for "Cancer"

Available Technologies

07HSC024 Method of targeted depletion of gastrointestinal and cancer stem cells

03NOR036 Cytotoxic Agent Targeted to Cancer Cells

05HSC018 Evaluation Methodology for Contrast Uptake in Tumors

04HSC001 A Cell-Based Assay for Small Molecule Inhibitors of the Mitotic Spindle Checkpoint/Metaphase Checkpoint Pathway

06HSC040 Blood Test for Pancreatic Cancer

05HSC050 Identification of Tumor-Specific Sequences and Alterations in Immune Responses in Peripheral Blood Circulating Cells of Cancer-Bearing Patients for Cancer Screening

07NOR004 New Cancer Treatment Aimed at Destruction of Cancer Tumors

04HSC058 Sindbis Virus and Related Plus-Stranded RNA Viruses as Oncolytic Reagents for Cancer Therapy

00HSC027 The Hyaluronan Receptor for Endocytosis (HAS) and Uses Thereof

06HSC003 Identification of Drugs to Target Suppressed Cancer Cells

05HSC040 Prevention of Cancer by Reversing Abnormal Differentiation and Inducing Apoptosis

05HSC039 Induction of Apoptosis Through Regulation of Gene Expression

05HSC038 Regulation of the Hepatocyte Nuclear Factor-4 (HNF-4) Receptor

05HSC037 Inhibition of Angiogenesis and Expression of Genes Involved in Blood Vessels

04HSC053 Comprehensive Detection and Identification of Tumor-specific Sequences and Potential Changes in Immune Responses in Circulating Cells of Peripheral Blood Using Suppression Subtractive Hybridization-based Differential Gene Expression Analysis

04HSC061 Use of conjugated Polyunsaturated Fatty Acids as Anti-Cancer and Anti-Angiogenic Agents

Licensed Technologies

07HSC026 Use of a novel curcumin analog to treat colon cancer

05HSC012 Development and Use of a Chimeric Protein for Therapy of Bleeding Disorders and Cancer

06NOR034 New Cancer Treatment Aimed at the Detection and Destruction of Cancer Tumors

07NOR001 New Cancer Treatment Aimed at Destruction of Cancer Tumors [With Nomadics Info]

03HSC035 High throughput screening method to identify inhibitors of gamma-glutamyl transpeptidase (GGT)